Antigenic subunits of Hantaan virus expressed by baculovirus and vaccinia virus recombinants.

AUTOR(ES)

Schmaljohn, C S

RESUMO

Baculovirus and vaccinia virus vectors were used to express the small (S) and medium (M) genome segments of Hantaan virus. Expression of the complete S or M segments yielded proteins electrophoretically indistinguishable from Hantaan virus nucleocapsid protein or envelope glycoproteins (G1 and G2), and expression of portions of the M segment, encoding either G1 or G2 alone, similarly yielded proteins which closely resembled authentic Hantaan virus proteins. The expressed envelope proteins retained all antigenic sites defined by a panel of monoclonal antibodies to Hantaan virus G1 and G2 and elicited antibodies in animals which reacted with authentic viral proteins. A Hantaan virus infectivity challenge model in hamsters was used to assay induction of protective immunity by the recombinant-expressed proteins. Recombinants expressing both G1 and G2 induced higher titer antibody responses than those expressing only G1 or G2 and protected most animals from infection with Hantaan virus. Baculovirus recombinants expressing only nucleocapsid protein also appeared to protect some animals from challenge. Passively transferred neutralizing monoclonal antibodies similarly prevented infection, suggesting that an antibody response alone is sufficient for immunity to Hantaan virus.

Documentos Relacionados

• Expression of the Bacillus anthracis protective antigen gene by baculovirus and vaccinia virus recombinants.
• Protection of mice and swine from pseudorabies virus conferred by vaccinia virus-based recombinants.
• Characterization and replicase activity of double-layered and single-layered rotavirus-like particles expressed from baculovirus recombinants.
• Plaque size phenotype as a selectable marker to generate vaccinia virus recombinants.
• Neomycin resistance as a dominant selectable marker for selection and isolation of vaccinia virus recombinants.